The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Abstract
Although the role of the T(H)1 and T(H)17 subsets of helper T cells as disease mediators in autoimmune neuroinflammation remains a subject of some debate, none of their signature cytokines are essential for disease development. Here we report that interleukin 23 (IL-23) and the transcription factor RORγt drove expression of the cytokine GM-CSF in helper T cells, whereas IL-12, interferon-γ (IFN-γ) and IL-27 acted as negative regulators. Autoreactive helper T cells specifically lacking GM-CSF failed to initiate neuroinflammation despite expression of IL-17A or IFN-γ, whereas GM-CSF secretion by Ifng(-/-)Il17a(-/-) helper T cells was sufficient to induce experimental autoimmune encephalomyelitis (EAE). During the disease effector phase, GM-CSF sustained neuroinflammation via myeloid cells that infiltrated the central nervous system. Thus, in contrast to all other known helper T cell-derived cytokines, GM-CSF serves a nonredundant function in the initiation of autoimmune inflammation regardless of helper T cell polarization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Th2 cells regulate multiple non-immune tissue cells at mucosal sites”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [25]
In the citing paper
“GM-CSF is essential for the development and progression of EAE. Mice deficient in GM-CSF are resistant to EAE induction, and blockade of GM-CSF in wild-type mice suppresses ongoing disease (McQualter et al., 2001; Codarri et al., 2011).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Codarri et al., 2011
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K. P., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,819
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,848
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,001
GM‐CSF therapy inhibits chronic graft‐versus‐host disease via expansion of regulatory T cells
Hotta, M., Yoshimura, H., Satake, A., Tsubokura, Y., Ito, T., & Nomura, S. (2018) · European Journal of Immunology · doi:10.1002/eji.201847684 · Cited by 31
Bone marrow chimeras—a vital tool in basic and translational research
Ferreira, F. M., Palle, P., Berg, J. V., Prajwal, P., Laman, J. D., & Buch, T. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01783-z · Cited by 31
“This concept was used in the second example study, in which the intrinsic capability of T cells as IL-23-mediated driver of GM-CSF production was identified [22].”
MethodZhang, F., Zhang, Y., Yang, T., Ye, Z.-Q., Tian, J., Fang, H.-R., Han, J., Wang, Z.-Z., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00863 · Cited by 26
“On the other hand, GM-CSF, which can be produced by both Th1 and Th17 cells, is required for encephalitogenicity of these pathogenic T-cell subsets (Codarri et al., 2011; El-Behi et al., 2011).”
BackgroundPotential for Targeting Myeloid Cells in Controlling CNS Inflammation
Ifergan, I., & Miller, S. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571897 · Cited by 33
Barone, M., Mendozzi, L., D’Amico, F., Saresella, M., Rampelli, S., Piancone, F., Rosa, F. L., Marventano, I., Clerici, M., d’Arma, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137173 · Cited by 32
“Interestingly, the relative abundance of Collinsella was positively correlated with CD4+/ROR-γ+ TH17 levels, suggesting the ability of this bacterial genus to support autoimmune neuroinflammation by inducing IL-17 production by ROR-γ+ TH17 cells [30,66].”
BackgroundDeubiquitylating enzymes: potential target in autoimmune diseases
Parihar, N., & Bhatt, L. K. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00890-z · Cited by 31
Luo, H., Broux, B., Wang, X., Hu, Y., Ghannam, S., Jin, W., Larochelle, C., Prat, A., & Wu, J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.013 · Cited by 32
GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
Kim, I., Koh, C., Jeon, I., Shin, K., Kang, T.-S., Bae, E., Seo, H., Ko, H., Kim, B., Chung, Y., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0518 · Cited by 31
Producing GM-CSF: a unique T helper subset?
Herndler-Brandstetter, D., & Flavell, R. (2014) · Cell Research · doi:10.1038/cr.2014.155 · Cited by 32
Hansen, R. H., Chow, H. H., Christensen, J. R., Sellebjerg, F. T., & von Essen, M. R. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101451 · Cited by 34
Chang, Y.-N., Kim, J. W., Yang, S., Chung, D., Ko, J., Moon, J., & Kim, H. Y. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1311 · Cited by 25
“Although GM-CSF has a protective effect, it also acts as an essential mediator of tissue inflammation.(35,36) GM-CSF exacerbates colitis by promoting the accumulation of Ly-6C inflammatory monocytes(17,18); namely, NCR ILC3s promote inflammation through GM-CSF-induced accumulation of inflammatory monocytes in the anti…”
BackgroundElevated CSF histamine levels in multiple sclerosis patients
Kallweit, U., Aritake, K., Bassetti, C. L., Blumenthal, S., Hayaishi, O., Linnebank, M., Baumann, C. R., & Urade, Y. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-19 · Cited by 30
“The cytokine granulocytemacrophage colony-stimulating factor (GM-CSF) in auto-reactive T helper cells is mandatory to induce and sustain EAE in mice [6].”
BackgroundTbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology
Brucklacher-Waldert, V., Ferreira, C., Innocentin, S., Kamdar, S., Withers, D. R., Kullberg, M. C., & Veldhoen, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600137 · Cited by 30
Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases
Krebs, C. F., & Panzer, U. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.005 · Cited by 31
Similarities and Differences Between Juvenile and Adult Spondyloarthropathies
Fisher, C., Ciurtin, C., Leandro, M. J., Sen, D., & Wedderburn, L. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.681621 · Cited by 31
“IL23 is less well-studied in ERA.”
BackgroundInfluentialBakema, J. E., Tuk, C. W., van Vliet, S. J., Bruijns, S. C. M., Vos, J. B., Letsiou, S., Dijkstra, C. D., van Kooyk, Y., Brenkman, A. B., & van Egmond, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1303126 · Cited by 29
“Furthermore, IL-23–dependent secretion of GM-CSF by Th cells was shown to evoke experimental autoimmune encephalomyelitis and sustain neuroinflammation (16).”
BackgroundInfluentialIκBNS Regulates Murine Th17 Differentiation during Gut Inflammation and Infection
Annemann, M., Wang, Z., Plaza-Sirvent, C., Glauben, R., Schuster, M., Sander, F. E., Mamareli, P., Kühl, A., Siegmund, B., Lochner, M., et al. (2015) · Journal of Immunology · doi:10.4049/jimmunol.1401964 · Cited by 29
“Expression of GM-CSF was reported to be responsible for the pathogenicity of Th17 cells during experimental autoimmune encephalomyelitis (EAE) (9, 10), the murine disease model for multiple sclerosis.”
BackgroundInfluentialDeleterious versus protective autoimmunity in multiple sclerosis
Kostić, M. S., Stojanović, I. R., Marjanović, G., Živković, N., & Cvetanović, A. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.04.006 · Cited by 30
Huber, M., & Lohoff, M. D. (2015) · Allergo Journal International · doi:10.1007/s40629-015-0038-4 · Cited by 29
Cheng, H., Xi, Y., Chi, X., Wu, Y., & Liu, G.-Z. (2016) · Central European Journal of Immunology · doi:10.5114/ceji.2016.58817 · Cited by 28
“Recently it has been reported that “classical” Th17 cells, which mainly produce IL-17, are not pathogenic, while GM-CSF is critical for the pathogenicity of Th17 cells [5, 6].”
The Emerging Complexity of γδT17 Cells
McKenzie, D. R., Comerford, I., Silva‐Santos, B., & McColl, S. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00796 · Cited by 29
Yang, M., Sun, L., Han, J., Zheng, C., Liang, H., Zhu, J., & Jin, T. (2019) · Molecular Brain · doi:10.1186/s13041-019-0532-6 · Cited by 32
“GMCSF mice fail to induce EAE because of the inability of autoreactive lymphocytes to proliferate and the ceasing of immune cell infiltration [120, 127].”
BackgroundConstitutive Expression of CCL22 Is Mediated by T Cell–Derived GM-CSF
Piseddu, I., Röhrle, N., Knott, M. M. L., Moder, S., Eiber, S., Schnell, K., Vetter, V. K., Meyer, B., Layritz, P., Kühnemuth, B., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000004 · Cited by 29
Hoffman, W., Passmore, G., Hannon, D., Talor, M., Fox, P., Brailer, C., Haislip, D., Keel, C. P., Harris, G., Rose, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071905 · Cited by 28
“Type 1 diabetes is marked by an increase of inflammatory cytokines/chemokines, such as IL-6; sCD40L [23,24]; IL-8 [25]; IL-1a; IL-2; IL-4; IL-5; IL-10; granulocytemacrophage colony-stimulating factor (GM-CSF); macrophage inflammatory protein (MIP)-1a; MIP-1b; and activation of normal T cell expressed and secreted (RAN…”
BackgroundInfluentialO'Connor, R., Li, X., Blumerman, S., Anderton, S., Noelle, R., & Dalton, D. (2012) · Journal of Immunology · doi:10.4049/jimmunol.1101118 · Cited by 24
Yang, Y., Winger, R. C., Lee, P. W., Nuro-Gyina, P. K., Minc, A., Larson, M., Liu, Y., Pei, W., Rieser, E. L., Racke, M. K., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12441 · Cited by 29
The influence of sodium on pathophysiology of multiple sclerosis
Zostawa, J., Adamczyk-Zostawa, J., Sowa, P., & Adamczyk-Sowa, M. H. (2017) · Neurological Sciences · doi:10.1007/s10072-016-2802-8 · Cited by 32
“The Th17 cells induced by high-salt concentration upregulate the production of pro-inflammatory cytokines GM-CSF, TNFa, IL-2, IL-9, several chemokines [131, 132], and CCR6 [133], which are”
BackgroundShaping immune landscape of colorectal cancer by cholesterol metabolites
Bai, Y., Li, T., Wang, Q., You, W., Yang, H., Xu, X., Li, Z., Zhang, Y., Yan, C., Yang, L., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-023-00015-9 · Cited by 31
Saligrama, N., Case, L., del Río, R., Noubade, R., & Teuscher, C. (2013) · Journal of Immunology · doi:10.4049/jimmunol.1203137 · Cited by 28
An emerging role of interleukin-23 in rheumatoid arthritis
Yuan, N., Yu, G., Liu, D., Wang, X., & Zhao, L. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1610429 · Cited by 29
“It has been reported that GM-CSF-deficient mice are resistant to EAE and GM-CSF-deficient Th17 cells fail to pass on EAE to naive recipients [60,64].”
BackgroundREGγ controls Th17 cell differentiation and autoimmune inflammation by regulating dendritic cells
Zhou, L., Yao, L., Zhang, Q., Xie, W., Wang, X., Zhang, H., Xu, J., Lin, Q., Li, Q., Yang, X., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0287-0 · Cited by 29
IL-23 in arthritic and inflammatory pain development in mice
Lee, M.-C., Zhang, Z., Achuthan, A. A., Fleetwood, A. J., Smith, J. E., Hamilton, J. A., & Cook, A. D. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02212-0 · Cited by 29
“Links between IL-23 and GM-CSF in macrophages and dendritic cells (DCs) have been noted [27–30], and IL-23-dependent secretion of GM-CSF by Th cells has been shown to be crucial in EAE development [15, 16].”
BackgroundMetabolic regulation and function of T helper cells in neuroinflammation
Spiljar, M., & Kuchroo, V. K. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00959-z · Cited by 29
Crosstalk between epithelium, myeloid and innate lymphoid cells during gut homeostasis and disease
Ghilas, S., O’Keefe, R. N., Mielke, L. A., Raghu, D., Büchert, M., & Ernst, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.944982 · Cited by 30
Jun, S.-M., Ochoa-Repáraz, J., Złotkowska, D., Hoyt, T. R., & Pascual, D. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.003 · Cited by 29
“Themajor CNS-invading CD4+ T cells are T helper type 1 cells (Th1) and Th17 cells, which produce inflammatory cytokines IFN-γ and IL-17, respectively.”
BackgroundInfluentialModulation of T-cell Mediated Immunity by Dopamine Receptor D5
Prado, C. E., Bernales, S., & Pacheco, R. (2013) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530311313020007 · Cited by 28
Mitchell, D. K., Shireman, J. M., Potchanant, E. A. S., Lara-Velazquez, M. A., & Dey, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.716947 · Cited by 27
Digoxin Attenuates Acute Cardiac Allograft Rejection by Antagonizing RORγt Activity
Wu, J., Zhou, C., Chen, W., Xie, A., Li, J., Wang, S., Ye, P., Wang, W., & Xia, J. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a48f5 · Cited by 27
Błyszczuk, P., Behnke, S., Lüscher, T. F., Eriksson, U., & Kania, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.008 · Cited by 27
Qu, X., Han, J., Zhang, Y., Wang, X.-Q., Fan, H., Hua, F., & Yao, R.-Q. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1579-0 · Cited by 31
Cold Atmospheric Plasma: An Emerging Immunomodulatory Therapy
Liu, H., Liang, X., Teng, M., Li, Z., Peng, Y., Wang, P., Hu, C., Cheng, H., & Liu, G. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202300399 · Cited by 26
Role of T Follicular Helper cells in Multiple Sclerosis.
Schmitt, N. (2015) · PubMed · Cited by 25
Hao, W., Decker, Y., Schnöder, L., Schottek, A., Li, D., Menger, M. D., Fassbender, K. C., & Liu, Y. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.01.004 · Cited by 24
Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage
Griffin, D. E. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0434-6 · Cited by 25
“cells and recruits myeloid cells into the CNS, but themechanism by which this leads to disease has not been identified [47, 50, 51].”
BackgroundParsa, R., Lund, H., Tosevski, I., Zhang, X., Malipiero, U., Beckervordersandforth, J. C., Merkler, D., Prinz, M., Gyllenberg, A., James, T., et al. (2016) · Glia · doi:10.1002/glia.23033 · Cited by 29
“The exact action of GM-CSF is disputed but the main target of GM-CSF during CNS inflammation is considered to be monocytes, this process being absolutely required for induction of EAE (Hesske et al., 2010; Codarri et al., 2011, 2013; Greter et al., 2012; Croxford et al., 2015).”
BackgroundJayaraman, A. K., Soni, A., Prabhakar, B. S., Holterman, M., & Jayaraman, S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.015 · Cited by 26
“[50-52] or Th17 cells alone [45-46, 49-51], could mediate EAE.”
BackgroundSeshadri, S., Allan, D., Carlyle, J. R., & Zenewicz, L. A. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006690 · Cited by 26
Yan, W.-L., Wu, C.-C., Shen, K., & Liu, S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002758 · Cited by 26
Shao, S., Chen, C., Shi, G.-N., Zhou, Y., Wei, Y.-Z., Wu, L., Sun, L., & Zhang, T.-T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.026 · Cited by 23
Direct and Indirect Regulatory Mechanisms in TH17 cell Differentiation and Functions
Bi, Y., & Yang, R. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02686.x · Cited by 27
Zhou, H., Wang, Y., Lian, Q., Yang, B., Ma, Y., Wu, X., Sun, S., Liu, Y., & Sun, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201343744 · Cited by 26
TLR 7 signaling exacerbates CNS autoimmunity through downregulation of F oxp3+ T reg cells
Lalive, P. H., Benkhoucha, M., Tran, N. L., Kreutzfeldt, M., Merkler, D., & Santiago‐Raber, M. (2013) · European Journal of Immunology · doi:10.1002/eji.201242985 · Cited by 26
Jones, G. W., Greenhill, C., Williams, J. O., Nowell, M. A., Williams, A. S., Jenkins, B. J., & Jones, S. A. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203771 · Cited by 27
Yeh, W.-I., McWilliams, I. L., & Harrington, L. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100031 · Cited by 26
“expression of this cytokine by CD4 T cells is essential for the development of EAE (18, 19).”
BackgroundTransgenic Expression of GM-CSF in T Cells Causes Disseminated Histiocytosis
van Nieuwenhuijze, A. E. M., Coghill, E., Gray, D. H. D., Prato, S., Metcalf, D., Alexander, W. S., & Wicks, I. P. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.014 · Cited by 27
Dendritic cells as therapeutic targets in neuroinflammation
Lüssi, F., Zipp, F., & Witsch, E. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2170-9 · Cited by 26
“This approach is currently investigated in phase II clinical trials in patients with rheumatoid arthritis in which two antibodies (MOR103 and KB003) designed to block GM-CSF signalling are being tested, after MOR103 demonstrated preliminary evidence of efficiency in this autoimmune disease [209].”
BackgroundInfluentialFurther understanding of the immunopathology of multiple sclerosis: impact on future treatments
Bhise, V. V., & Dhib-Jalbut, S. S. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1191351 · Cited by 28
NLRP3 gain-of-function in CD4+ T lymphocytes ameliorates experimental autoimmune encephalomyelitis
Braga, T. T., Brandão, W. N., de Azevedo, H. F. Z., Terra, F. F., de Melo, A. C. L., Pereira, F. V., Andrade‐Oliveira, V., Hiyane, M. I., Peron, J. P. S., & Câmara, N. O. S. (2019) · Clinical Science · doi:10.1042/cs20190506 · Cited by 29
Regulation of Th17 Differentiation by IKKα-Dependent and -Independent Phosphorylation of RORγt
He, Z., Wang, F., Zhang, J., Sen, S., Pang, Q., Luo, S., Gwack, Y., & Sun, Z. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700457 · Cited by 29
Sendo, S., Saegusa, J., Okano, T., Takahashi, S., Akashi, K., & Morinobu, A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40231 · Cited by 27
“Some CD4+ T cells produce GM-CSF under inflammatory conditions (31,32).”
BackgroundIL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production
Yoshimura, S., Thomé, R., Konno, S., Mari, E. R., Rasouli, J., Hwang, D., Boehm, A., Lǐ, Y., Zhang, G., Ćirić, B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801113 · Cited by 25
Luo, L., Hu, X., Dixon, M. L., Pope, B. J., Leavenworth, J. D., Raman, C., Meador, W. R., & Leavenworth, J. W. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02076-4 · Cited by 26
CD4 + T cells require Ikaros to inhibit their differentiation toward a pathogenic cell fate
Bernardi, C., Maurer, G., Ye, T., Marchal, P., Jost, B., Wissler, M., Maurer, U., Kastner, P., Chan, S. H., & Charvet, C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023172118 · Cited by 25
T helper cell populations: As flexible as the skin?
Waisman, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141938 · Cited by 25
Stability of T-cell lineages in autoimmune diseases
Raphael, I., & Forsthuber, T. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.22 · Cited by 22
The balance of intestinal Foxp3 + regulatory T cells and Th17 cells and its biological significance
Shen, X., Du, J., Guan, W., & Zhao, Y. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.882232 · Cited by 25
Mannie, M. D., Blanchfield, L., Islam, S. M. T., & Abbott, D. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00255 · Cited by 25
“These findings indicate that the high affinity docking of the cytokine domain to cytokine receptors on APC was the key event for potentiated antigen recognition.”
BackgroundRecent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis
Wootla, B., Watzlawik, J. O., Stavropoulos, N., Wittenberg, N. J., Dasari, H., Abdelrahim, M. A., Henley, J. R., Oh, S., Warrington, A. E., & Rodriguez, M. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1158809 · Cited by 25
“Under these conditions, breakdown of BBB may in fact be beneficial, as this will result in an increased influx of NAbs or drugs with reparative properties to target and protect intrinsic cells of the CNS.[125] Nonetheless, the emergence of new molecules or techniques that would promote easier and safer crossing of the…”
BackgroundInfluentialKhanam, A., Trehanpati, N., & Sarin, S. K. (2018) · Liver International · doi:10.1111/liv.14015 · Cited by 25
CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses
Woo, J. S., Srikanth, S., Kim, K., Elsaesser, H. J., Lu, J. N., Pellegrini, M. A., Brooks, D. G., Sun, Z., & Gwack, Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800659 · Cited by 22
“GM-CSF has also been identified as an important cytokine that contributes to the pathogenicity of inflammatory T cells in EAE by inducing activation and recruitment of innate immune cells (25, 26).”
BackgroundWei, Y., Peng, L., Li, Y., Zhang, N., Shang, K., Duan, L., Zhong, J., & Chen, J. (2020) · Journal of Immunology Research · doi:10.1155/2020/3891425 · Cited by 24
“TNF-α and IFN-γ , which are Th1-related cytokines, are considered as the key proin fl ammatory cytokines in the progression of human RA [4, 5].”
Adult Onset Still's Disease and Autoinflammation
Efthimiou, P., Moorthy, L. N., Mavragani, C. P., Skokos, D., & Fautrel, B. (2012) · International Journal of Inflammation · doi:10.1155/2012/964751 · Cited by 24
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice
Zayoud, M., Malki, K., Frauenknecht, K., Trinschek, B., Kloos, L., Karram, K., Wanke, F., Georgescu, J., Hartwig, U., Sommer, C., et al. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9466-4 · Cited by 24
“The increased levels for human GM-CSF and IFN-γ mRNA were CNS-specific as mRNA levels of total splenocytes showed only low levels of cytokine expression in both groups.”
BackgroundInfluentialKarin, N., & Wildbaum, G. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.037 · Cited by 25
Midkine and multiple sclerosis
Takeuchi, H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12499 · Cited by 25
Thomé, R., Moore, J. N., Mari, E. R., Rasouli, J., Hwang, D. H., Yoshimura, S., Ćirić, B., Zhang, G., & Rostami, A. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01392 · Cited by 23
Kamei, A., Wu, W., Traficante, D. C., Koh, A. Y., van Rooijen, N., Pier, G. B., & Priebe, G. P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis657 · Cited by 24
G-CSF and Neutrophils Are Nonredundant Mediators of Murine Experimental Autoimmune Uveoretinitis
Goldberg, G. L., Cornish, A. L., Murphy, J. E., Pang, E. S., Lim, L. L., Campbell, I. K., Scalzo‐Inguanti, K., Chen, X., McMenamin, P. G., Maraskovsky, E., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.008 · Cited by 24
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Aram, J., Francis, A. G., Tănăsescu, R., & Constantinescu, C. S. (2018) · Neurology and Therapy · doi:10.1007/s40120-018-0120-1 · Cited by 22
Whitehead, G. S., Kang, H. S., Thomas, S. Y., Medvedev, A. V., Karcz, T. P., Izumi, G., Nakano, K., Makarov, S., Nakano, H., Jetten, A. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125528 · Cited by 24
“As seen in the previous experiments, TNF was also significantly reduced, whereas GM-CSF was not.”
BackgroundInfluentialMast cells and angiogenesis in multiple sclerosis
Ribatti, D., Tamma, R., & Annese, T. (2020) · Inflammation Research · doi:10.1007/s00011-020-01394-2 · Cited by 22
Brain-homing CD4 + T cells display glucocorticoid-resistant features in MS
Koetzier, S. C., van Langelaar, J., Blok, K. M., van den Bosch, T. P. P., Wierenga‐Wolf, A. F., Melief, M., Pol, K., Siepman, T. A. M., Verjans, G. M. G. M., Smolders, J., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000894 · Cited by 22
Wu, S., Ma, R., Zhong, Y., Chen, Z., Zhou, H., Zhou, M., Chong, W. P., & Chen, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147517 · Cited by 24
“GM-CSF has been shown to be an important pathogenic cytokine from Th17 cells in neuroinflammation [27].”
BackgroundJamann, H., Cui, Q., Desu, H. L., Pernin, F., Tastet, O., Halaweh, A., Farzam‐kia, N., Mamane, V. H., Ouédraogo, O., Cleret‐Buhot, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.850616 · Cited by 24
Neuroinflammation: Extinguishing a blaze of T cells
Benallegue, N., Kébir, H., & Alvarez, J. I. (2022) · Immunological Reviews · doi:10.1111/imr.13122 · Cited by 25
Prajapati, P. S., & Doshi, G. (2023) · Current Drug Targets · doi:10.2174/0113894501276093231206064243 · Cited by 26
Th17 Cells Induce a Distinct Graft Rejection Response That Does Not Require IL-17A
Agorogiannis, E. I., Regateiro, F. S., Howie, D., Waldmann, H., & Cobbold, S. P. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03971.x · Cited by 23
“It is also possible that neither IL-17A nor IL-17F are essential to the rejection process mediated by Th17 cells (59), with granulocytemacrophage colony stimulating factor (CSF2) (60,61) and IL-22 (62) as other candidates to be excluded.”
BackgroundSingh, S., Barr, H. L., Liu, Y., Robins, A., Heeb, S., Williams, P. M., Fogarty, A., Cámara, M., & Martínez‐Pomares, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117447 · Cited by 23
TCF-1 inhibits IL-17 gene expression to restrain Th17 immunity in a stage specific manner
Zhang, J., He, Z.-H., Sen, S., Wang, F., Zhang, Q., & Sun, Z.-M. (2018) · Journal of Immunology · doi:10.4049/jimmunol.1800193 · Cited by 20
Garnier, L., Laffont, S., Lélu, K., Yogev, N., Waisman, A., & Guéry, J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800417 · Cited by 24
“genic Th17 cells is essential for the induction of neuroinflammation in EAE (34, 35).”
BackgroundMechanisms and functions of IL-17 signaling in renal autoimmune diseases
Schmidt, T., Luebbe, J., Paust, H., & Panzer, U. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.005 · Cited by 23
“TH17 cells are characterized by the transcription factors RORγt and STAT3 (Ivanov et al., 2006; Nurieva et al., 2007), which orchestrate the production of the proinflammatory cytokines IL-17 A (referred to as IL-17), IL-17 F, IL-22, and GM-CSF (Codarri et al., 2011; Zenewicz et al., 2007), as well as the expression of…”
BackgroundInácio, D., Amado, T., Pamplona, A., Sobral, D., Cunha, C., Santos, R. F., Oliveira, L., Rouquié, N., Carmo, A. M., Lesourne, R., et al. (2025) · Nature Immunology · doi:10.1038/s41590-024-02073-8 · Cited by 24
“…mice at the peak of experimental autoimmune encephalomyelitis (EAE; SRA-SUB14032445), given that type 1 helper T (T H 1) cells and IL-17-producing helper T (T H 17) cells are not readily found at steady state but require an inflammatory challenge for their differentiation and expansion 11 .”
Andersen, J., & Brilot, F. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101944 · Cited by 22
Hu, Q., Shi, J., Zhang, J., Wang, Y., Guo, Y., & Zhang, Z. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100032 · Cited by 22
Dhib-Jalbut, S. S., Sumandeep, S., Valenzuela, R. M., Ito, K., Patel, P., & Rametta, M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.012 · Cited by 22
“Nevertheless, Th17 cells are pro-inflammatory as they have been shown to damage the BBB (Kebir et al., 2007) and also stimulate GM-CSF producing cells (Codarri et al., 2011).”
Ghosh, D., Curtis, A. D., Wilkinson, D., & Mannie, M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0815-359r · Cited by 20
“not mediate the adoptive transfer of EAE [14, 16].”
Role of the epigenetic factor Sirt7 in neuroinflammation and neurogenesis
Burg, N., Bittner, S., & Ellwardt, E. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.09.005 · Cited by 22
Zhu, J., Liu, J.-Q., Liu, Z., Wu, L., Shi, M., Zhang, J., Davis, J. P., & Bai, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00873 · Cited by 22
“We also observed that AAV-IL27 treatment inhibited the frequencies of GM-CSF-producing T cells in peripheral lymphoid organs in EAE protected mice, which is consistent with the known function of IL-27 in inhibiting GM-CSF production by T cells (17, 24).”
MethodResultInfluentialNitsch, L., Zimmermann, J., Krauthausen, M., Hofer, M. J., Saggu, R., Petzold, G. C., Heneka, M. T., Getts, D. R., Becker, A. J., Campbell, I. L., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1640-0 · Cited by 21
Liu, X., Zawidzka, E. M., Li, H., Lesch, C. A., Dunbar, J. E., Bousley, D., Zou, W., Hu, X., & Carter, L. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0714 · Cited by 22
“IL17A and IL17F bind to IL17 receptors on endothelial cells, stromal cells, and tumor cells (23) and induce the production of various chemokines such as CCL20, CXCL9, and CXCL10, which recruit monocytes, neutrophils, natural killer (NK) cells, and CD8þ T cells into the tumor microenvironment (24, 25).”
Background
Metadata
- Authors
- Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B.
- Affiliations
- University Hospital Zurich (CH)
- University of Zurich (CH)
- Merck Serono S.A. (Switzerland) (CH)
- Corresponding author
- Becher, Burkhard
- Venue
- Nature Immunology
- Published
- 2011-04-24
- Volume
- 12
- Issue
- 6
- Pages
- 560-567
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2157837362
- Cited by
- 1,191
- References
- 44
- Citations by year
- 2026: 31 · 2025: 48 · 2024: 60 · 2023: 53 · 2022: 61 · 2021: 73 · 2020: 85 · 2019: 83 · 2018: 72 · 2017: 99 · 2016: 96 · 2015: 117 · 2014: 103 · 2013: 98 · 2012: 82
- FWCI
- 70.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- RORγt, GM-CSF, experimental autoimmune encephalomyelitis, T helper cells, IL-23, autoimmune neuroinflammation, Th1 cells, Th17 cells, myeloid cell infiltration, IL-12, interferon-gamma, IL-27, cytokine regulation
- MeSH terms
- Animals, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Glycoproteins, T-Lymphocytes, Helper-Inducer, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Transgenic, Peptide Fragments, Granulocyte-Macrophage Colony-Stimulating Factor, Mice, Knockout, Th1 Cells, Interleukin-12, Interleukin-17, Mice, Interleukin-23, Nuclear Receptor Subfamily 1, Group F, Member 3, Th17 Cells, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review